ORKA CIK: 907654

Oruka Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
42.7
FY23:
37.6
FY24:
0.00
FY24:
377
FY25:
344
(positive)
Change from FY22 to FY25
millions USD
FY22:
0.39
FY23:
0.27
FY24:
0
FY24:
19.2
FY25:
145
Total assets
Change from FY22 to FY25
millions USD
FY22:
43.1
FY23:
37.9
FY24:
0.00
FY24:
396
FY25:
489

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
1.13
FY23:
0.64
FY24:
–
FY24:
13.0
FY25:
15.4
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.28
FY23:
0.20
FY24:
–
FY24:
0.76
FY25:
1.31
(positive)
Change from FY22 to FY25
millions USD
FY22:
41.7
FY23:
37.0
FY24:
0.00
FY24:
382
FY25:
472
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
43.1
FY23:
37.9
FY24:
–
FY24:
396
FY25:
489

All amounts in millions USD Data sources:SEC EDGARTwelve Data